This Week in PLoS Medicine: Rapid diagnostics; Heart health & diabetes; Follow-up in HIV treatment & more
At the close of October, PLoS Medicine published 5 new articles, including the monthly editorial:
The PLoS Medicine editors reflect on recent research and analysis that highlight the need to fully evaluate rapid diagnostics.
Using Mendelian randomization, Roman Pfister and colleagues demonstrate a potentially causal link between low levels of B-type natriuretic peptide (BNP), a hormone released by damaged hearts, and the development of type 2 diabetes.
Based on a statistical analysis of 111 facilities in Africa, Asia, and Latin America, Benjamin Chi and colleagues develop a standard loss-to-follow-up (LTFU) definition that can be used by HIV antiretroviral programs worldwide.
Justin Lessler and colleagues describe a method that estimates the fraction of a population accessible to vaccination activities and apply it to measles vaccination in three African countries: Ghana, Madagascar, and Sierra Leone.
Valentina Gallo and colleagues provide detailed guidance for authors to improve their reporting of epidemiological studies involving biomarkers. The guidance is a Molecular Epidemiology extension of the STROBE Statement.
Remember you can comment on, annotate and rate any PLoS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.